Hypothyroidism and AMH in Iraqi Patients with Chronic Kidney Disease

This study was conducted to investigate thyroid function and Anti-Müllerian hormone (AMH) in (Chronic kidney disease) CKD patients by evaluating their levels in CKD patients, 50 patients were diagnosed to have CKD stage-5, their ages ranged between 20-50 years (25 males and 25 females) who attended...

Full description

Saved in:
Bibliographic Details
Main Authors: Noori M. Luaibi, Athraa K. Falhi, Ali J. Alsaedi
Format: Article
Language:English
Published: University of Baghdad, College of Science for Women 2021-03-01
Series:مجلة بغداد للعلوم
Subjects:
Online Access:https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/3681
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study was conducted to investigate thyroid function and Anti-Müllerian hormone (AMH) in (Chronic kidney disease) CKD patients by evaluating their levels in CKD patients, 50 patients were diagnosed to have CKD stage-5, their ages ranged between 20-50 years (25 males and 25 females) who attended the Nephrology and Transplant Center in Medical City of Baghdad- Iraq, they were recruited from April 2018 to July 2018 and were enrolled into the study. The control group consisted of 20 healthy individuals, their ages ranged between 20-48 years (10 males and 10 females). The study showed non-significant (p>0.05) increase in AMH level in CKD patients compared to the control group. On the other hand, TSH was recorded a highly significant (P<0.01) increase in CKD patients in comparison with control. While T3 and T4 levels recorded highly significant (P<0.01) decrease in CKD patients in comparison with control.
ISSN:2078-8665
2411-7986